Table 3.
Statistically significant CpG sites whose PFAS-associated methylation differences differed over time ( FDR ) in the HOME Study (Cincinnati, Ohio; enrolled 2003–2006) and associations in Project Viva (eastern Massachusetts; enrolled 1999–2002).
| CpGa | Gene | Chr | HOME Study ( value) |
FDR -value | HOME Study ( value) |
HOME Study ( value) |
Project Viva ( value) |
Replicated |
|---|---|---|---|---|---|---|---|---|
| PFHxS | ||||||||
| cg12507840 | UBAC2; MIR548AN | 13 | () | 0.011 | 0.041 (0.009) | (0.021) | NA | No |
| cg12119988 | ANKDD1A | 15 | 0.012 () | 0.011 | (0.290) | 0.093 (0.0004) | (0.766) | No |
| cg11035296 | DLGAP2-AS1 | 8 | () | 0.030 | 0.044 (0.028) | (0.020) | NA | No |
| cg21869609 | LINGO3 | 19 | () | 0.030 | 0.028 (0.093) | (0.160) | (0.343) | No |
| PFNA | ||||||||
| cg24155143 | — | 4 | () | 0.021 | 0.14 (0.004) | (0.0001) | NA | No |
Note: Adjusted for child age and sex, annual household income, maternal smoking during pregnancy and race, and cell type composition. —, not annotated to any known gene; , shows the association between gestational PFAS and DNA methylation at birth; , shows the association between gestational PFAS and DNA methylation at 12 years of age; CpG, cytosine–guanine dinucleotide; Chr, chromosome; FDR, false discovery rate; HOME, Health Outcomes and Measures of the Environment; NA, not available in 450K microarray; PFAS, perfluoroalkyl substances; PFHxS, perfluorohexane sulfonate; PFNA, perfluorononanoate; PFOA, perfluorooctanoate; PFOS, perfluorooctane sulfonate.
Statistically significant CpG sites were defined as having an FDR for .